@文章{信息:doi/10.2196/11655，作者="Na, Xu and Guo, Haihong and Zhang, Yu and Shen, Liu and Wu, Sizhu and Li, Jiao"，标题="挖掘开放支付数据:2014-2016年胸外科医生行业支付分析"，期刊="J医学互联网研究"，年="2018"，月="11"，日="30"，量="20"，数="11"，页数="e11655"，关键词="开放支付数据;医药行业;胸的外科医生;背景:在全球范围内，医生与行业之间的财务关系已成为一个备受争议的问题。美国《平价医疗法案》(2010年)的《医生支付阳光法案》通过在“开放支付计划”数据库中公开薪酬数据，提高了行业和医生之间交易的透明度。与此同时，根据世界卫生组织的数据，大多数非传染性疾病死亡是由心血管疾病引起的。目的:本研究旨在调查胸外科医生获得的非研究性和非所有权性报酬的分布情况，探讨行业与胸外科医生财务关系的规律性。方法:从2014-2016年开放支付计划一般支付数据集中获得年度统计数据。我们描述了单笔支付交易超过10,000美元的年度付款分布，量化了主要费用类别(如薪酬、咨询费、差旅和住宿)，并确定了30个支付最高的行业。此外，我们利用弦图可视化的方法，绘制出胸外科医生行业间的财务关系。 Results: The three highest categories with single payments greater than US {\$}10,000 were Royalty or License, Compensation, and Consulting Fees. Payments related to Royalty or License transferred from only 5.38{\%} of industries to 0.75{\%} of surgeons with the highest median (US {\$}13,753, {\$}11,992, and {\$}10,614 respectively) in 3-year period. In contrast, payments related to Food and Beverage transferred from 93.50{\%} of industries to 98.48{\%} of surgeons with the lowest median (US {\$}28, {\$}27, and {\$}27). The top 30 highest-paying industries made up approximately 90{\%} of the total payments (US {\$}21,036,972, {\$}23,304,996, and {\$}28,116,336). Furthermore, just under 9{\%} of surgeons received approximately 80{\%} of the total payments in each of the 3 years. Specifically, the 100 highest cumulative payments, accounting for 52.69{\%} of the total, transferred from 27 (6.05{\%}) pharmaceutical industries to 86 (1.89{\%}) thoracic surgeons from 2014-2016; 7 surgeons received payments greater than US {\$}1,000,000; 12 surgeons received payments greater than US {\$}400,000. The majority (90{\%}) of these surgeons received tremendous value from only one industry. Conclusions: There exists a great discrepancy in the distribution of payments by categories. Royalty or License Fees, Compensation, and Consulting Fees are the primary transferring channels of single large payments. The massive transfer from industries to surgeons has a strong ``apical dominance'' and excludability. Further research should focus on discovering the fundamental driving factors for the strong concentration of certain medical devices and how these payments will affect the industry itself. ", issn="1438-8871", doi="10.2196/11655", url="//www.mybigtv.com/2018/11/e11655/", url="https://doi.org/10.2196/11655", url="http://www.ncbi.nlm.nih.gov/pubmed/30504119" }